Physician
Allied Physicians Group, PLLC
Allied Physicians Group, PLLC was paid $33.90M by Medicaid between Jan 2018 and Dec 2024, across 116 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 49% of everything it billed.
33Billing provider infoALLIED PHYSICIANS GROUP, PLLC
MELVILLE, NY 11747
MELVILLE, NY 11747
33aNPI1396944799assigned 07/16/2007
33bProvider typeFamily Medicine Physician
28Total paid$33.90M
24GClaims832,316
24DCodes billed116
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Family Medicine Physician providers in New York
Rank by total paid#5 of 2,605
Median peer was paid$10K
This provider vs. median3,358×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 45,239 | $1.93M | |
| 2019 | 81,674 | $3.07M | |
| 2020 | 122,159 | $4.02M | |
| 2021 | 158,461 | $5.37M | |
| 2022 | 145,581 | $6.97M | |
| 2023 | 140,889 | $6.55M | |
| 2024incomplete | 138,313 | $6.01M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 49% | 187,610 | 177,764 | $16.62M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 17% | 45,725 | 43,429 | $5.74M |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 9.3% | 101,023 | 100,239 | $3.15M |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 5.0% | 16,321 | 16,302 | $1.71M |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 4.5% | 14,395 | 14,394 | $1.51M |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 2.4% | 8,427 | 8,334 | $809K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 2.1% | 6,157 | 6,154 | $714K |
| 87428 | 1.4% | 10,560 | 10,281 | $468K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 1.3% | 11,808 | 11,553 | $434K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 2,666 | 2,610 | $293K |
| 96160 | <1% | 74,218 | 69,377 | $235K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 4,090 | 3,965 | $208K |
104 more codes
| 92552 | <1% | 6,870 | $187K | |
| 92551 | <1% | 20,700 | $177K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 22,499 | $162K |
| 96127 | <1% | 29,330 | $162K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 11,492 | $162K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 17,943 | $112K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 2,098 | $85K |
| 99051 | <1% | 18,473 | $76K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 399 | $73K |
| 92587 | <1% | 2,891 | $69K | |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 791 | $64K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 2,362 | $44K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 10,586 | $43K |
| 99173 | <1% | 20,403 | $42K | |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | <1% | 419 | $42K |
| 90461 | <1% | 2,162 | $40K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 2,107 | $39K |
| T1013 | Sign language or oral interpretive services, per 15 minutes | <1% | 3,266 | $39K |
| 0072A | <1% | 909 | $37K | |
| 0071A | <1% | 883 | $37K | |
| 87070 | <1% | 5,729 | $33K | |
| 87184 | <1% | 6,984 | $31K | |
| 81002 | <1% | 12,864 | $27K | |
| 85018 | <1% | 11,126 | $23K | |
| 95018 | <1% | 411 | $23K | |
| 0002A | <1% | 515 | $21K | |
| 0001A | <1% | 503 | $21K | |
| 92567 | <1% | 1,739 | $20K | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 546 | $18K |
| 81003 | <1% | 8,779 | $15K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 82 | $13K |
| 90686 | <1% | 20,741 | $11K | |
| 83655 | <1% | 890 | $11K | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | <1% | 573 | $8K |
| 80061 | Lipid panel | <1% | 1,143 | $6K |
| 99429 | <1% | 521 | $5K | |
| 95165 | Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials | <1% | 235 | $5K |
| 99177 | <1% | 3,290 | $4K | |
| 95117 | <1% | 288 | $3K | |
| 94010 | <1% | 114 | $3K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 25 | $3K |
| 82947 | <1% | 817 | $3K | |
| 0004A | <1% | 53 | $2K | |
| 85014 | <1% | 944 | $2K | |
| D1206 | Topical application of fluoride varnish | <1% | 74 | $1K |
| 99417 | Prolong home eval add 15m | <1% | 52 | $1K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 12 | $1K |
| 99442 | <1% | 27 | $1K | |
| 94664 | <1% | 88 | $1K | |
| 87807 | <1% | 165 | $1K | |
| 81000 | <1% | 271 | $970.35 | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 19 | $872.38 |
| 90480 | <1% | 22 | $789.16 | |
| 82465 | <1% | 210 | $786.99 | |
| 90671 | <1% | 928 | $745.96 | |
| 99072 | <1% | 38,823 | $692.97 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 731 | $671.39 |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 36 | $659.89 |
| 87081 | <1% | 200 | $570.32 | |
| 36416 | <1% | 25,181 | $554.00 | |
| 99188 | <1% | 42 | $515.73 | |
| 90656 | <1% | 1,893 | $473.02 | |
| 90698 | <1% | 2,298 | $321.30 | |
| 99401 | <1% | 12 | $310.35 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 28 | $306.63 |
| 90661 | <1% | 611 | $228.86 | |
| 90651 | <1% | 147 | $217.11 | |
| 99441 | <1% | 14 | $203.96 | |
| 90688 | <1% | 1,220 | $188.50 | |
| 90670 | <1% | 2,012 | $160.65 | |
| 96161 | <1% | 80 | $136.04 | |
| 81025 | <1% | 14 | $108.36 | |
| 36410 | <1% | 12 | $96.90 | |
| 90685 | <1% | 501 | $88.84 | |
| 90682 | <1% | 12 | $69.94 | |
| 92283 | <1% | 80 | $60.00 | |
| 99174 | <1% | 12 | $53.48 | |
| 2014F | <1% | 42 | $40.00 | |
| 90744 | <1% | 171 | $32.39 | |
| 90672 | <1% | 95 | $23.70 | |
| 87400 | <1% | 104 | $22.50 | |
| 90680 | <1% | 662 | $17.85 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 28 | $1.28 |
| 91307 | <1% | 2,257 | $0.18 | |
| 91300 | <1% | 1,591 | $0.11 | |
| 91301 | <1% | 12 | $0.01 | |
| 99000 | 0% | 11,122 | $0.00 | |
| 90620 | 0% | 13 | $0.00 | |
| 99070 | 0% | 634 | $0.00 | |
| 90619 | 0% | 102 | $0.00 | |
| 90696 | 0% | 14 | $0.00 | |
| 90716 | 0% | 25 | $0.00 | |
| 3011F | 0% | 60 | $0.00 | |
| 90697 | 0% | 24 | $0.00 | |
| 3074F | 0% | 13 | $0.00 | |
| 3725F | 0% | 471 | $0.00 | |
| 90633 | 0% | 332 | $0.00 | |
| 90710 | 0% | 64 | $0.00 | |
| 90715 | 0% | 15 | $0.00 | |
| 90734 | 0% | 66 | $0.00 | |
| 90713 | 0% | 27 | $0.00 | |
| 90700 | 0% | 14 | $0.00 | |
| 90648 | 0% | 24 | $0.00 | |
| 90707 | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialFROMMER, KERRY (CEO)